Gene Query: PPFIA1

Dataset Description Geneva Score
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 42.16
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 35.55
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 27.61
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 23.76
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 22.74
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 21.0
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 20.19
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 19.67
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 19.53
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 18.5
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 17.09
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 16.55
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 16.55
RNAseq Study in CC-671 Treated Cal-51 Cells 15.21
Neonatal and adult human testis defined at the single-cell level 14.99
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 14.88
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 14.85
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 14.71
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 14.5
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 14.31
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 13.92
Recovery and analysis of nascent RNA 13.92
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 13.11
Integrin signaling regulates YAP/TAZ to control skin homeostasis 12.97
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 12.9
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 12.51
Survival of pancreatic cancer cells lacking KRAS function 12.41
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 12.34
R430: A potent inbibitor of DNA and RNA viruses 12.27
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 11.91
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 11.69
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 11.61
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 11.46
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 11.39
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 11.16
An RNA-centric dissection of host complexes controlling flavivirus infection 10.5
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 10.5
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 10.43
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 10.37
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 10.26
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 10.26
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 10.21
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 10.11
TCF7L1 knockdown in pancreatic cancer 10.07
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 10.02
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 10.02
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 10.01
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 9.9
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 9.88
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 9.85
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 9.85
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 9.82
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 9.74
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 9.74
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 9.69
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 9.68
Genes significantly down or Up-regulated upon RNF219 knockdown 9.66
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 9.56
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 9.33
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 9.24
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 9.2
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 9.16
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 9.1
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 9.1
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 9.05
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 9.04
RNA sequencing of GlyH-101-treated MCF-7 cell line 9.03
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 9.02
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 8.97
RNA-seq analysis of AML cells in response to ASLAN003 8.96
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 8.93
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 8.77
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 8.76
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 8.74
snRNAs as regulators of alternative splicing 8.66
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 8.65
Hijacking of stress response machinery by oncogenes in acute leukaemia 8.65
Active translatome profiling with RiboLace in MCF7 cells 8.58
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 8.55
Mapping interactions for the TNIP2 hub protein 8.52
Gene expression profiling of leukemia cells following asparagine depletion 8.51
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 8.44
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 8.35
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 8.35
RNA sequencing of mechanically strained NHEKs and control NHEKs 8.32
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 8.27
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 8.26
Human HAP1 cells before and after nutrient deprivation 8.23
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 8.23
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 8.21
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 8.21
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 8.2
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 8.2
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 8.2
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 8.16
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 8.15
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 8.15
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 8.06
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 8.04
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 8.03
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 7.96
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 7.85
RNA-seq of YB5 cells treated with Proscillaridin A 7.84
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 7.82
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 7.81
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 7.72
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 7.71
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 7.71
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 7.71
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 7.71
mRNA sequencing of oropharyngeal cancer cell lines 7.65
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 7.62
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 7.53
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 7.53
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 7.5
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 7.36
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 7.36
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 7.34
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 7.32
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 7.29
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 7.26
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 7.19
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 7.15
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 7.15
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 7.15
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 7.13
NR2F2 study 7.11
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 7.11
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 7.07
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 7.05
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 7.05
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 7.04
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 7.0
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 6.95
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 6.94
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 6.91
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 6.88
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 6.84
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 6.84
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 6.83
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 6.76
Toxoplasma gondii infection of human retinal pigment epithelial cells 6.76
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 6.75
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 6.75
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 6.71
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 6.67
MYCL and EP400 are required for Max and MCPyV mediated gene activation 6.67
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 6.65
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 6.64
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 6.6
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 6.6
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 6.59
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 6.59
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 6.55
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 6.53
miRNAs affected by antagomiR-17 treatment 6.51
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 6.48
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 6.48
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 6.45
LINE-2 transposable elements are a source of functional human microRNAs and target sites 6.43
U1 snRNP telescripting regulates size-function stratified human genome 6.43
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 6.34
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 6.33
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 6.31
Comparing gene expression in iPSC derived RPE from control and AMD donors 6.27
3’ Uridylation Expands miRNA Target Repertoire 6.26
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 6.26
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 6.25
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 6.25
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 6.24
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 6.24
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 6.22
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 6.21
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 6.19
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 6.19
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 6.15
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 6.15
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 6.13
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 6.12
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 6.11
High-throughput sequencing of PROMPT-enriched samples. 6.11
ETV7 and interferon response 6.08
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 6.08
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 6.08
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 6.05
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 6.04
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 6.03
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 6.01
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 6.01
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 6.01
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 5.97
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 5.91
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 5.86
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 5.86
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 5.85
Knockdown of ADNP in HCT116 colon cancer cells 5.84
Capturing the Interactome of Newly Transcribed RNA (RICK) 5.79
Capturing the Interactome of Newly Transcribed RNA 5.79
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 5.78
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 5.77
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 5.76
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 5.65
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 5.64
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 5.63
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 5.59
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 5.57
NKX2.2 5.56
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 5.56
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 5.51
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 5.48
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 5.42
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 5.42
circRNA profile in hypopharyngeal cancer 5.4
Genome wide miR-191 target profile determined by RIP and gene expression profiling 5.39
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 5.39
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 5.37
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 5.35
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 5.29
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 5.29
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 5.26
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 5.24
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 5.17
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 5.16
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 5.16
Differetially expressed genes after hTR overexpression in U2OS cells 5.12
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 5.09
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 5.07
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 5.04
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 5.01
Copper Regulation of HIF-1 Transcription Activity 5.01
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 5.01
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 5.01
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 4.97
Transcriptional profiling of microglia; current state of the art and future perspectives 4.94
RNA-sequencing 4.91
SNHG5 siRNA knock down in HCT116 cells 4.89
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 4.86
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 4.85
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 4.85
A transcriptome dataset revealing the molecular features of breast cancer stem cells 4.84
RNA-seq of naive and primed ES cells 4.83
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 4.83
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 4.83
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 4.82
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 4.81
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 4.78
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 4.73
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 4.68
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 4.67
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.65
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 4.61
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 4.58
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 4.57
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 4.51
The cohesin complex prevents Myc-induced replication stress 4.49
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 4.44
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 4.42
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 4.42
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 4.4
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 4.4
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 4.4
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 4.37
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 4.37
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 4.28
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 4.28
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 4.19
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 4.14
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 4.14
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 4.14
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 4.13
CSL RNA-Seq on HKC and SCC cell lines 4.11
CSL 4.11
RNA expression analysis upon JMJD1C depletion 4.09
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 4.09
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 4.09
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 4.07
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 4.06
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 3.99
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 3.98
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 3.98
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 3.97
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 3.97
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 3.97
RNA Seq of HMVEC under hypoxia 3.95
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 3.95
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 3.89
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 3.88
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 3.87
oxLDL exposed trained monocytes 3.86
Transcriptomes of oxLDL exposed trained monocytes 3.86
Molecular Criteria for Defining the Naive Human Pluripotent State 3.85
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 3.83
Conservative alteration of chromosomal expression pattern across human solid tumor types 3.79
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 3.78
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 3.74
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 3.74
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 3.69
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 3.67
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 3.65
METTL3 and WTAP 3.64
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 3.63
PRDM1 inhibits proliferation of human colon cancer organoids 3.6
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 3.6
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 3.6
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 3.58
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 3.57
Genetic-to-epigenetic Therapy for Pancreatic Cancer 3.53
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 3.5
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 3.46
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 3.46
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 3.46
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 3.44
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 3.44
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 3.44
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 3.43
The transcriptome effect of overexpressing EZH2 in MCF7 3.42
Trascriptome of thyroid cancer-induced macrophages 3.41
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 3.39
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 3.39
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 3.37
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.37
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 3.35
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 3.34
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 3.34
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 3.34
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 3.33
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 3.33
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 3.31
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.28
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 3.23
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 3.21
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 3.15
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 3.14
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 3.13
Human cells contain natural double-stranded RNAs with potential regulatory capacity 3.11
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 3.09
RNA-seq of RKO cells with cTAZ KO or putback 3.09
SLIGRL-induced gene expression changes in NHEK cells 3.02
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 3.02
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 3.02
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 3.0
X-Ray induced DNA-Hydroxymethylation changes 2.95
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.94
Microprocessor mediates transcription termination in long noncoding microRNA genes 2.93
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 2.93
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.85
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 2.82
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 2.75
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.71
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 2.7
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 2.7
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 2.7
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 2.69
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 2.66
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 2.66
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.66
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 2.66
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 2.66
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 2.66
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 2.64
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 2.63
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 2.62
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 2.61
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 2.61
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 2.59
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 2.59
Real-time observation of light-controlled transcription in living cells 2.54
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 2.53
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 2.53
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 2.51
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 2.51
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.51
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 2.49
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 2.48
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 2.47
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 2.46
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 2.38
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.36
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.36
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 2.34
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 2.25
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 2.16
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 2.16
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 2.13
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 2.12
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 2.04
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 2.01
An siRNA screen identifies CHD4 as a target for epigenetic therapy 2.0
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.94
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 1.93
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 1.88
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 1.88
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.81
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 1.77
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 1.77
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 1.73
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 1.69
UV_24h_GRO-Seq 1.61
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 1.59
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 1.58
Transposon-based construction of strand-specific RNA-seq libraries 1.55
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 1.53
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 1.5
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 1.5
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 1.48
Transcriptional responses of melanoma cells to BRAF inhibition 1.46
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.4
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 1.37
The circadian transcriptional landscape in primary human mammary epithelial cells 1.37
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 1.35
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 1.35
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 1.35
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 1.31
Differential responses of human fetal brain neural stem cells to Zika virus infection 1.28
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 1.25
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 1.21
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 1.21
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 1.21
AUF-1 affected genes in human skin cells 1.14
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.13
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 1.09
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 1.09
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 1.09
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.08
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.07
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.0
Effect of ILF3 on translation during homeostasis and the antiviral response 0.99
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.99
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.99
Effects of transcription on genome - nuclear lamina interactions 0.98
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.98
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 0.98
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 0.96
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 0.96
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.94
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.94
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 0.92
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 0.92
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 0.9
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 0.88
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 0.88
Gene expression profile in breast cancer cells 0.85
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 0.85
Interaction between mitoNEET and NAF-1 in cancer cells 0.85
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 0.65
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 0.63
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 0.62
Function and hormonal regulation of GATA3 in human first trimester placentation 0.59
CD74 role in transcription regulation 0.58
CD74 role in transcription regulation [RNA-seq] 0.58
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.58
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.58
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.58
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.5
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.48
A single-cell transcriptome atlas of the human pancreas 0.46
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.46
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.44
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.44
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 0.44
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 0.43
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 0.4
mRNA-sequencing of breast cancer subtypes and normal tissue 0.38
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 0.37
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 0.37
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 0.36
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.35
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.34
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.33
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 0.32
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 0.32
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 0.32
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.32
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.31
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.31
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.27
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.27
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.25
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.22
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.22
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.22
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.21
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.2
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 0.19
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 0.19
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.18
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.16
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.16
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 0.12
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.12
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.09
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.09
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 0.08
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.08
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.05
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.04
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.03
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.01
Modulation of nonsense-mediated decay by rapamycin 0.0
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation